Drugs / ACH04
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02949089 | Jan 2013 → Sep 2014 | diarrheal disease | Ache Laboratorios Farmaceuticos S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACH04 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02949089 ↗ |
| Route | Oral | “repeated oral doses of ACH04” NCT02949089 ↗ |